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Abstract
The major histocompatibility complex (MHC) is a highly polymorphic genomic region
that encodes the transplantation and immune regulatory molecules. It receives special
attention for genetic investigation because of its important role in the regulation of
innate and adaptive immune responses and its strong association with numerous
infectious and/or autoimmune diseases. Recently, genotyping of the polymorphisms
of MHC genes using targeted next-generation sequencing (NGS) technologies was
developed for humans and some nonhuman species. Most species have numerous
highly homologous MHC loci so the NGS technologies are likely to replace traditional
genotyping methods in the near future for the investigation of human and animal
MHC genes in evolutionary biology, ecology, population genetics, and disease and
transplantation studies. In this chapter, we provide a short review of the use of
targeted NGS for MHC genotyping in humans and nonhuman species, particularly
for the class I and class II regions of the Crab-eating Macaque MHC (Mafa).
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1. Introduction
The major histocompatibility complex (MHC) genomic region consists of a large group of
evolutionary-related genes involved functionally with the innate and adaptive immune
systems in jawed vertebrates [1]. In humans, the MHC is located on the short arm of chromo‐
some 6, band p21.3, and the MHC class I and class II genomic regions encode the highly
polymorphic gene complex classified as the human leukocyte antigen (HLA) complex [2, 3].
The HLA class I and class II molecules expressed by the MHC play important roles in restricted
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cellular interactions and tissue histocompatibility due to cellular discrimination of “self” and
“nonself” that require an essential knowledge of the effects of HLA allele matched and
mismatched donors in transplantation medicine [4] and transfusion therapy [5]. While the
HLA class I molecules are expressed by all nucleated cells to present processed peptides of
intracellular origin to CD8+ cytotoxic T cells and serve as ligands for natural killer cells, the
class II molecules are expressed by antigen-presenting cells such as B cells, dendritic cells, or
macrophages to present exogenous peptides to CD4+ helper T cells of the immune system [6].
In addition, the classical HLA class I genes, HLA-A, HLA-B, and HLA-C, and the classical
HLA class II genes, HLA-DR, HLA-DQ, and HLA-DP are distinguished by their extraordinary
polymorphisms, whereas the nonclassical HLA class I genes, HLA-E, HLA-F, and HLA-G, are
distinguished by their tissue-specific expression and limited polymorphism [2, 3, 7].
The highly polymorphic HLA genomic region is critically involved in the rejection and graft-
versus-host disease (GVHD) of hematopoietic stem cell transplants [8, 9], the pathogenesis of
numerous autoimmune diseases [10–13], and infectious diseases [14]. Apart from regulating
immunity, the MHC genes may have a role in reproduction and social behavior, such as
pregnancy maintenance, mate selection, and kin recognition [15]. The MHC genomic region
also appears to influence drug adverse reactions [16, 17], CNS development and plasticity [18–
22], neurological cell interactions [23, 24], synaptic function and behavior [25, 26], cerebral
hemispheric specialization [27], and neurological and psychiatric disorders [28–32]. Hence, the
MHC is one of the most biomedically important genomic regions that warrant special attention
for genetic investigation.
In general, the study of the diversity and polymorphic variation of the MHC genomic region
has been focused more on humans than any other species and animal population [1] largely
because of the high cost and limited throughput of the first generation Sanger sequencing
method [33, 34]. However, this is now changing because the next-generation sequencing (NGS)
technologies are becoming the method of choice for lower-cost, high-throughput genotyping
of MHC genes that are composed of highly homologous multiple loci such as those found in
the macaque primate species [35]. Thus, the NGS technologies are expected to perform precise
MHC genotyping in human and model animals that already have a collection of MHC allele
references, and to facilitate MHC genotyping of wild animals that as yet have no MHC allele
references. In addition, the NGS technologies are likely to replace traditional genotyping
methods such as subcloning, Sanger sequencing, and previously developed PCR-based MHC
typing methods (PCR-RFLP, PCR-SSP, and so on) in the near future. Recently, many articles
concerning the development of NGS technologies for precise MHC genotyping and genotyp‐
ing data of MHC genes using the new NGS technologies have been published on the investi‐
gations of human and nonhuman MHC polymorphisms in various fields of study such as
medical science, evolutionary biology, ecology, and population genetics.
In this chapter, we provide a short review of the current HLA polymorphism information and
the use of PCR-based NGS for MHC genotyping in human and nonhuman species, particularly
for the Filipino crab-eating macaque MHC (Mafa) class I (Mafa-A, -B, -E, -F, and -I) and class
II loci (Mafa-DPA1, -DPB1, -DQA1, -DQB1, and -DRB1).
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2. HLA allele number
A total of 13,840 HLA allele sequences, 10,297 in the class I and 3543 in the class II gene re‐
gions, were released by the IMGT/HLA database [7] release 3.22 in October 2015 (Table 1).
Category Locus Allele no. Protein no.
Class I HLA-A 3285 2313
HLA-B 4077 3011
HLA-C 2801 1985
HLA-E 18 7
HLA-F 22 4
HLA-G 51 17
Pseudogene 43 0
Total 10,297 7337
Class II HLA-DRA 7 2
HLA-DRB1 1825 1335
HLA-DRB3 60 48
HLA-DRB4 17 10
HLA-DRB5 22 19
HLA-DQA1 54 32
HLA-DQB1 876 595
HLA-DPA1 42 21
HLA-DPB1 587 480
HLA-DMA 7 4
HLA-DMB 13 7
HLA-DOA 12 3
HLA-DOB 13 5
Pseudogene 8 0
Total 3543 2561
Table 1. Number and genomic distribution (loci) of HLA alleles
The IMGT/HLA database is a specialist database for HLA sequences. Ten years ago, the
allelenumbers were only 2182, but since then, the numbers have increased by 1000 allele
sequenceseach year. Of 10,297 HLA class I alleles, 3285, 4077, 2801, 18, 22, and 51 alleles were
countedin HLA-A, HLA-B, HLA-C, HLA-E, HLA-F, and HLA-G genes, respectively (Table 1);
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10,163 and91 alleles were counted in the classical and nonclassical HLA class I genes, respec‐
tively.Of the 3543 HLA class II alleles, 7, 1825, 99, 54, 876, 42, 587, 7, 13, 12, and 13 alleles were
countedin HLA-DRA, HLA-DRB1, HLA-DRB3/4/5, HLA-DQA1, HLA-DQB1, HLA-DPA1,
HLA-DPB1, HLA-DMA, HLA-DMB, HLA-DOA, and HLA-DOB genes, respectively (Table
1), with3490 and 45 alleles in the classical and nonclassical HLA class II genes, respectively.
3. History of HLA genotyping methods
Many variations of the conventional HLA genotyping methods such as incorporating restric‐
tion fragment polymorphisms (RFLP) [36], single strand conformation polymorphism (SSCP)
[37], sequence-specific oligonucleotides (SSOs) [38], sequence-specific primers (SSPs) [39], and
sequence-based typing (SBT), like the Sanger method [33], have been used for the efficient and
rapid HLA matching in transplantation therapy [40–43], research into HLA-related diseases
[2, 3], population diversity studies [44–46], and in forensic and paternity testing [47]. The HLA
genotyping methods mainly applied today are PCR-SSOP, such as the Luminex commercial
methodology [48, 49], and SBT by the Sanger method employing capillary sequencing based
on chain–termination reactions [33, 34]. However, both methods often detect more than one
pair of unresolved HLA alleles because of chromosomal phase (cis/trans) ambiguity [50, 51].
To solve the phase ambiguity problem, new HLA genotyping technologies have been reported
and commercialized that combine the PCR amplification of targeted HLA genomic regions
with NGS platforms such as the ion PGM system (Life Technologies), GS Junior system
(Roche), and the MiSeq system (Illumina) [52}. The PCR/NGS methods are expected to produce
genotyping results that detect new and null alleles efficiently without phase ambiguity.
4. Summary of NGS-based human MHC genotyping methods
Table 2 shows list of publications on NGS-based human MHC genotyping that includes
information for PCR range, targeted HLA locus, NGS platform, and allele assignment method.
The MHC genotyping methods in human are basically composed of three steps, PCR, NGS,
and allele assignment. We summarize the important points in each of the three steps below.
The more detailed information is described in our previous publication [52].
4.1. PCR step
4.1.1. Long- and short-range PCR
PCR methods produce amplicons of different sequence lengths depending on the primer
design and the type of DNA polymerase used for the PCR. The amplicon sizes are usually
classified into two size ranges: the short-range system where the amplicon size is <1 kb and
the long-range system where the amplicon size is >1 kb as shown in Figure 1.
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The short-range PCR system is a method based on PCR amplification of each exon that includes
polymorphic exons 2 and 3 in HLA-A, HLA-B, and HLA-C and exon 2 in HLA-DR, HLA-DQ,
and HLA-DP. One of the advantages of the short-range system is that it is the most suitable
for application of physically fragmented DNA samples as templates such as those extracted
from swabs because the PCR length is relatively short, ranging from 250 bp to 900 bp, per
No. PCR range Sorting from
PCR range
Targeted HLA locus NGS platform Allele assignment
method
Ref.
1 410–790 bp Short-range
system
A, B, C, DRB1/3/4/5,
DQA1, DQB1, DPB1
454 GS FLX Conexio Assign ATF [66]
2 400–900 bp Short-range
system
A, B 454 GS FLX GS-FLX amplicon variant
analyzer
[67]
3 Unknown Long-range
system
A, B, C, DRB1, DQB1 454 GS FLX Conexio Assign-NG [51]
4 410–790 bp Short-range
system
A, B, C, DRB1/3/4/5,
DQA1, DQB1, DPB1
454 GS FLX Conexio Genomics ATF [68]
5 381–537 bp Short-range
system
A, B, C 454 GS FLX SSAHA2 [69]
6 4.6–11.2 kb Long-range
system
A, B, C, DRB1, DQA1,
DQB1, DPA1, DPB1
454 GS Junior,
Ion PGM
SeaBass [70]
7 2.7–4.1 kb Long-range
system
A, B, C, DRB1 HiSeq2000, Miseq Alignment with
IMGT/HLA data
[71]
8 410–790 bp Short-range
system
A, B, C, DRB1/3/4/5,
DQA1, DQB1, DPB1
454 GS FLX, (or
GS Junior)
Conexio Assign ATF 454 [72]
9 3.4–13.6 kb Long-range
system
A, B, C, DRB1, DPB1,
DQB1
MiSeq BWA, Samtools, GATK,
PerlScript
[73]
10 5.1–5.6 kb Long-range
system
DRB3, DRB4, DRB5 454 GS Junior SeaBass [74]
11 250–270 bp Short-range
system
A, B, C, DRB1, DPB1,
DQB1
MiSeq neXtype [75]
12 250–270 bp Short-range
system
DRB1/3/4/5, DQA1,
DQB1, DPA1, DPB1
MiSeq Genetics Management
System
[76]
13 Unknown Long-range
system
A, B, DRB1 PacBio Bayes’ theorem,
NGSengine
[77]
14 4.0–7.2 kb Long-range
system
A, B, C, DRB1/3/4/5,
DQB1, DPB1
Ion PGM SeaBass [54]
Table 2. Publication list of NGS-based MHC genotyping in human. Bold letter shows publications from the author’s
group
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amplicon. On the other hand, the short-range system is less effective for genotyping recombi‐
nant alleles that have been generated by recombination events of the HLA genes because it is
difficult to avoid the phase ambiguities generated by recombinations. For example, in Figure
2, B*15:20 has an identical nucleotide sequence with B*15:01 in exon 2 and B*35:01 in exon 3,
but B*35:43 has an identical nucleotide sequence with B*35:01 in exon 2 and B*15:01 in exon 3.
When we genotype a DNA sample that has B*15:01 or B*15:20 and B*35:01 or B*35:43, ambig‐
uous genotyping can result in assignments such as B*15:01/20 and B*35:01/43 that are difficult
to assign correctly and definitively.
The long-range PCR system is a method based on PCR amplification of the entire HLA gene
region including the promotor-enhancer region, 5′ untranslated region (UTR), all exons, all
introns, and the 3′ UTR or partial gene regions that include polymorphic exons and adjacent
introns (Figure 1). Primer sets for long-range systems have already been developed and
published for HLA-A, HLA-B, HLA-C, HLA-DRB1/3/4/5, HLA-DQA1, HLA-DQB1, HLA-
DPA1, and HLA-DPB1 (Table 2). The advantage of long-range PCR is that this system can
easily solve phase ambiguity even if recombinant alleles such as those shown in Figure 2 are
present in DNA samples. Also, the long-range PCR method is expected to detect new poly‐
morphisms and variations throughout the entire HLA gene region. Therefore, the long-range
Figure 1. Outline of NGS-based human MHC typing.
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system is an important and useful alternative to the short-range system for donor-recipient
matching in bone marrow transplantation and HLA-related disease studies. In fact, one of the
main themes of the upcoming 17th International HLA and Immunogenetics Workshop
(IHIWS) in 2017 [53] is “NGS of full length HLA genes,” with the following objectives: (1) to
complete the sequence of all HLA alleles of the reference cell lines from the 13th IHIWS and
(2) to perform HLA genotyping of 10,000 quartet families of varied ancestry, utilizing at least
one NGS method.
4.1.2. Development of multiplex PCR methods
Recently, we developed four kinds of multiplex PCR methods based on the long-range system
for genotyping nine HLA loci (HLA-A, -B, -C, -DRB1/3/4/5, -DQB1, and -DPB1) [54] (Figure 3).
Figure 3. Two different nine loci HLA genotyping procedures at the PCR step.
Figure 2. Example of recombinant HLA alleles. B*15:01 and B*15:20 and B*15:01 and B*35:43 have identical nucleotide
sequences in exon 2 and in exon 3, respectively (red boxes), and B*35:01 and B*35:43 and B*35:01 and B*15:20 have
identical nucleotide sequences in exon 2 and in exon 3, respectively (blue boxes). “X” indicates the recombination site.
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The multiplex PCR methods contributed greatly to simplifying, accelerating, and reducing
costs and the number of reagents for the PCR step that is used to prepare samples and libraries
for NGS in the NGS-based HLA genotyping method. The multiplex methods also conserved
on the amounts of DNA samples needed to genotype a multiple number of HLA loci. Overall,
the multiplex PCR method is a powerful tool for providing precise genotyping data without
phase ambiguity, with a strong potential to replace the current routine genotyping methods
to find polymorphisms. Commercialized PCR amplification reagents such as NEType (One‐
Lambda) that are based on multiplex PCR methods will be made available in the near future,
whereas those based on the one-locus, one-tube PCR methods (left side of Figure 3) such as
the TruSight HLA panel (Illumina) and NGSgo (GenDX) are already available in the market
place.
4.2. NGS step
Although the 454 GS FLX was used often in the early stages of development of NGS-based
HLA genotyping, the benchtop next-generation sequencers such as the GS Junior system, Ion
Torrent PGM system, and the MiSeq system have been used more recently for the development
and application of the HLA genotyping methods (Table 2). At the moment, complicated
operations such as the preparation of NGS libraries are necessary for each of the different
second generation sequencing platforms. However, the NGS companies are attempting to
overcome these procedural bottlenecks by simplifying, automating, and speeding-up of the
preparatory steps for NGS. For example, a new protocol using Ion Isothermal Amplification
Chemistry that enables sequence reads of up to and beyond 500 bp, and Ion Hi-Q™ Sequencing
Chemistry that reduces consensus insertion and deletion (indel) errors, including homopoly‐
mer errors, might lead to further simplification and cost reduction with higher data quality.
4.3. Allele assignment step
A variety of different allele assignment methods have been developed with some allele
assignment software packages such as Assign (CONEXIO), OMIXON Target (OMIXON), and
NGSengine (GenDX) commercially available, and others such as TypeStream (Life Technolo‐
gies) still to be made commercially available in the near future. From our knowledge, Assign
and NGSengine only support NGS data obtained from the one-locus, one-tube PCR method,
whereas OMIXON Target and TypeStream also support NGS data obtained by the multiplex
PCR methods. However, accuracy rates of the assignment methods are not 100% with
genotyping errors caused by (1) missing HLA allele sequences, (2) generation of excessive
allelic imbalance (ratio of sequence read numbers of allele 1 and allele 2), and (3) interference
of HLA-DRB1 genotyping by participation of sequence reads originating from highly homol‐
ogous HLA-DRB3/4/5 and other HLA-DRB pseudogenes. To avoid the errors raised in point
1, it is necessary to have a full and proper collection of all the HLA allele sequences to achieve
precise HLA genotyping. In this regard, a much greater collection of high-quality full-length
HLA allele sequences are expected to be obtained by way of international collaborations at the
17th IHIWS meeting in 2017 [53].
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4.3.1. In-house Sequence Alignment-Based Assigning Software (SeaBass)
Recently, we developed a new next sequence allele assignment program (Sequence Alignment-
Based Assigning Software; SeaBass) to solve the problems previously outlined in points 2 and
3 above. The program includes (1) output of sequence reads, (2) homology search using the
Blat program [55] with the “match” variable set to 100% to detect identical exons within the
known HLA alleles released from the IMGT-HLA database [7], (3) selection of allele candi‐
dates, (4) mapping of the sequence reads to the selected allele candidates as references with
the “match” set at 100% using Reference Mapper (Roche), (5) calculation of coverages, and (6)
confirmation of the mapping data and allele assignment (Figure 4).
Figure 4. Allele assignment method using the newly developed Sequence Alignment-Based Assigning Software, Sea‐
Bass.
The operations from Eqs. (2) to (5) are automatically processed. If a new polymorphism is
included in the exon, we can detect its presence at the Blat search stage as shown in Figure 5,
and if a new polymorphism is included in the intron, we can detect its presence during the
calculation of the coverage and the final confirmation stages (Figure 6).
After the detection of the new polymorphisms, we further confirm them by traditional
methods such as Sanger sequencing and subcloning. In addition, we validated the use of the
SeaBass assignment methods for three next-generation sequencers, the GS Junior system, the
Ion Torrent PGM system, and the MiSeq system. To evaluate the SeaBass program, we used a
total of 2414 HLA sequences from all the classical HLA loci that have frequent HLA alleles in
Caucasians, African-Europeans, and Japanese, and we obtained an overall accuracy rate of
>99.8% and 100% for the Japanese subjects (Table 3).
The accuracy rate was not 100% for HLA-DRB1/3/4/5 and HLA-DPB1 of the non-Japanese
subjects because the complete coding sequences have not been determined as yet for some of
their HLA-DRB and HLA-DPB1 alleles. Nevertheless, the allele assignment method that we
developed for SeaBass appears to be the most accurate and efficient way to detect new and
null alleles by NGS.
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Figure 5. Detailed information concerning selection of allele candidates using the SeaBass computer program. (A) “Ex‐
traction of allele candidates” by Blat search. We select allele candidates that are extracted in all of the exons. (B-1) New
allele detection. In this example, one allele was called B*15:18:01, but the other allele was called B*44:03:01 excluding
the exon 3. (B-2) Confirmation of the new allele by NGS. Mapping of the sequence reads with B*44:03:01 as a reference
suggested six nucleotide differences with B*44:03:01 were detected in exon 3. We confirmed the polymorphisms by
Sanger sequencing and deposited the sequence to DDBJ and IMGT-HLA database. Now the formal allele name is
B*44:184 [94].
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5. NGS-based MHC genotyping methods in nonhuman species
NGS technology provides the opportunity to genotype MHC sequences either by PCR targeted
DNA sequencing or by PCR targeted RNA sequencing, that is, by DNA sequencing after
converting the RNA samples to cDNA by reverse transcriptase. Usually, one or other of the
Figure 6. Detection of a new allele during the calculation of the coverage and final confirmation stages in SeaBass.
Mapping results of the sequence reads using GS Reference Mapper are shown. (A) In this case, there is no mismatch
between the reference and consensus sequence. (B) In this case, there is a mismatch between the reference and consen‐
sus sequence (reference: C; consensus: -) indicated by yellow background.
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sequencing methods is chosen rather than using both methods on the same samples. In the
following sections, we compare the use and limitations of targeted NGS sequencing using
DNA or RNA samples for MHC genotyping of MHC class I and class II genes in nonhuman
species such as the Filipino cynomolgus macaques.
5.1. Advantage and disadvantage of using DNA and RNA samples for NGS
Table 4 shows a summary of the advantages and disadvantages of using DNA and RNA
samples for NGS-based MHC genotyping.
DNA RNA
Difficulty of sampling Easy Difficult
Extraction cost of nucleic acid Cheap Expensive
Preparation before PCR No RT reaction
Primer location Both of exons and introns Exons only
Required sequence read number Few Many
Exclusion of pseudogene Difficult Easy
Estimation of expression level Impossible Possible
Table 4. Advantages and disadvantages of DNA and RNA samples for NGS-based MHC genotyping
Worldwide subject (1916 loci)
Total A C B DRB345 DRB1 DQA1 DQB1 DPA1 DPB1
Locus
number
1916 250 250 242 186 239 140 234 140 235
Allele
number
3832 500 500 484 372 478 280 468 280 470
Accuracy rate
(%)
99.8 100 100 100 99.2 99.6 100 100 100 99.6
Japanese subject (498 loci)
Total A C B DRB345 DRB1 DQA1 DQB1 DPA1 DPB1
Locus
number
498 86 80 77 50 68 4 65 4 64
Allele
number
996 172 160 154 100 136 8 130 8 128
Accuracy rate
(%)
100 100 100 100 100 100 100 100 100 100
Table 3. Evaluation of the SeaBass program
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The advantages of using DNA samples instead of RNA samples are that (1) the sampling and
extraction of the DNA nucleic acids are easier and cheaper than RNA samples, (2) PCR
amplification can be perform directly without an additional reaction such as the reverse
transcriptase (RT) reaction, (3) design of primers in the exon and intron regions, and (4) fewer
read sequences are required for DNA than RNA samples if all alleles are amplified without
allelic imbalance. Although many more read sequences are necessary for RNA samples than
DNA samples to genotype all the MHC alleles that have different transcription levels, the
advantages of using RNA samples for genotyping are that (1) they provide an opportunity to
examine MHC gene expression, (2) transcription levels are possible to be estimated for each
of MHC alleles from the read sequence depth [56], and (3) only transcribed MHC genes are
detected without contamination of PCR products originating from pseudogenes if the primer
locations cross over to at least two homologous exons. Thus, the use of RNA samples is thought
to be more effective for precise MHC genotyping on duplicated MHC genes that have high
similarities among the genes. However, DNA and RNA samples have their own unique
advantages and disadvantages for informative NGS-based MHC genotyping and widen the
choices for experimentation and data collection.
5.2. Methodology
Table 5 shows a publication list of the MHC genotyping by PCR-based NGS methods in
different animal species, and it includes the MHC species name, target gene, PCR method,
degree of allele data accumulation, and the allele assignment method.
Species MHC
name
Animal
model or
nonmodel
type
Templat
e
Target
gene
NGS
platform
Degree of
allele data
accumulation
Allele
assignment
method
Ref.
Mammal Rhesus
macaque
Mamu Model RNA Class I and
II
454,
Illumina
Relatively rich Mapping de
novo
assembly
[78, 79]
Cynomolgus
macaque
Mafa Model RNA Class I and
II
454,
Illumina,
PacBio
Relatively rich Mapping de
novo
assembly
[35, 78,
80, 81]
Pig-tailed
macaque
Mane Model RNA Class I and
II
454,
Illumina
Relatively rich Mapping de
novo
assembly
[78, 82]
Swine SLA Model RNA Class I 454 Relatively rich Mapping de
novo
assembly
[56]
Grey mouse
lemur
Mimu Nonmodel DNA DRB and
DQB
454 Poor De novo
assembly
[83]
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Species MHC
name
Animal
model or
nonmodel
type
Templat
e
Target
gene
NGS
platform
Degree of
allele data
accumulation
Allele
assignment
method
Ref.
Alpine
marmots
Mama Nonmodel DNA Class I and
DRB
454 Poor De novo
assembly
[84]
New Zealand
sea lion
Phho Nonmodel DNA DRB and
DQB
454 Poor De novo
assembly
[85]
Avian Collared
flycatcher
Fial Nonmodel DNA Class II 454 Poor De novo
assembly
[86]
Great tit Pama Nonmodel DNA Class I 454 Poor De novo
assembly
[87]
House
Sparrows
Pado Nonmodel DNA Class I 454 Poor De novo
assembly
[88]
Berthelot’s
pipittawny
pipit
AnbeAnc
a
Nonmodel DNA Class II 454 Poor De novo
assembly
[89]
New Zealand
passerine
Peph Nonmodel DNA Class II PGM Poor De novo
assembly
[90]
Eurasian Coot Fuat Nonmodel DNA Class II 454 Poor De novo
assembly
[91]
Reptile Ornate dragon
lizard
Ctor Nonmodel DNA Class I 454 Poor De novo
assembly
[92]
Fish Stickleback fish Gaac Nonmodel DNA Class II 454 Poor De novo
assembly
[93]
Table 5. Publication list of MHC genotyping by PCR-based NGS methods in nonhuman species
As discussed previously, for humans, the HLA alleles obtained by next-generation sequencers
are mainly assigned by mapping to known allele sequences that are used as the read references
because a large number of HLA allele sequences already have been collected in the IMGT-HLA
database [7] (Table 2). On the other hand, de novo assembly of read sequences and subcloning
of PCR products identifies novel allele sequences. Of the nonhuman species, RNA samples
tend to be used for MHC genotyping in experimental animals (model animals) such as
macaque species and swine, whereas DNA samples are mainly used for MHC genotyping wild
(nonmodel) animals because collecting RNA samples from them in their natural environment
is more difficult than sampling captured or domesticated experimental animals (Table 5).
5.2.1. MHC genotyping RNA samples collected from Filipino cynomolgus macaques
MHC alleles in humans and experimental animals such as the macaque species and swine are
mainly assigned by mapping methods because of the large amount of MHC allele information
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already available for them than for most other species. This allele information is collected and
released by the IPD-MHC database [57]. When novel alleles are detected, de novo assembly of
the read sequences and subcloning of PCR products identifies the sequences.
We identified homozygous and heterozygous cynomolgus macaques (Mafa) that have specific
Mafa MHC haplotypes by genotyping the MHC of more than 5000 Filipino animals, and we
found that they have a smaller number of different Mafa-class I and Mafa-class II alleles than
the Indonesian and Vietnamese populations. In this section, we outline the MHC genotyping
method using RNA samples and provide some results as an example of the method. Figure
7 shows a comparative genomic map of MHC regions between human and Filipino cynomol‐
gus macaque.
Figure 7. Comparative genomic map of the human (HLA) and the Filipino cynomolgus macaque (Mafa) Class I and
Class II transcribed genes.
The MHC class I genomic region has many more Mafa-class I genes than HLA-class I genes
generated by gene duplication events, whereas the organization of Mafa-class II genes are well
conserved between the two species. Also, there are many Mafa-class I pseudogenes located in
the Mafa-class I region. Therefore, we performed MHC genotyping by amplicon sequencing
with the Roche GS Junior system using RNA samples from the Filipino cynomolgus macaques
to prevent contamination of PCR products originating from the pseudogenes (Figure 8).
The workflow that we used is composed mainly of five steps: (1) RNA extraction and cDNA
synthesis, (2) multiplex PCR amplification, (3) pooling of the PCR products, (4) amplicon NGS
sequencing, and (5) allele assignment. In step 1, we usually extracted total RNA from the
peripheral white blood cell samples using the TRIzol reagent (Invitrogen/Life Technologies/
Thermo Fisher Scientific, Carlsbad, CA) and synthesized cDNA by oligo d(T) primer using the
ReverTraAce for the reverse transcriptase reaction (TOYOBO, Osaka, Japan) after treatment
of the isolated RNA with DNase I (Invitrogen/Life Technologies/Thermo Fisher Scientific,
Carlsbad, CA). In step 2, we designed a single Mafa-class I-specific primer set in exon 2 and
exon 4 (PCR product size: 514 bp or 517 bp) that could amplify all known Mafa-class I alleles,
whereas the Mafa-class II locus-specific primer sets included the polymorphic exon 2 in Mafa-
DRB (420 bp), Mafa-DQA1 (435 bp), Mafa-DQB1 (396 bp), Mafa-DPA1 (407 bp), and Mafa-
DPB1 (333, 336 or 339 bp) for massively parallel pyrosequencing (Figure 9).
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Figure 9. Location of primer sites to amplify Filipino cynomolgus macaque MHC genes. Yellow boxes and blue arrows
indicate polymorphic exons and PCR regions, respectively. Numbers indicate exon numbers.
In addition to these primer sets, we also designed 50 different types of fusion primers that
contained the 454 titanium adaptor (A in forward and B in reverse primer), 10 bp MID (multiple
identifier), and MHC-specific primers (Figure 8). Moreover, we constructed a multiplex PCR
method using the primer sets by carefully optimizing primer composition and PCR conditions
and by comparing the sequence read data obtained by NGS (Figure 10).
As a result of these primer designs, 51.5%, 13.6%, and 8.6–8.9% of all read sequence numbers
were detected in Mafa-class I, Mafa-DRB, and the other Mafa-class II genes, respectively, and
we confirmed that the genotypes obtained by the multiplex PCR method were consistent with
Figure 8. A schematic workflow of the successive steps of the MHC genotyping method by NGS amplicon sequencing
for the Filipino cynomolgus macaques.
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our previous uniplex PCR methods. Therefore, the multiplex PCR method greatly simplified
the procedures required in preparing the DNA samples for NGS by reducing the time of
preparation and the amount and cost of reagents. In the pooling step of the PCR products, we
quantified the purified PCR products by the Picogreen assay (Invitrogen) with a Fluoroskan
Ascent micro-plate fluorometer (Thermo Fisher Scientific, Waltham, MA), mixed each of the
PCR products at equimolar concentrations and then diluted them according to the manufac‐
ture’s recommendation. In the NGS amplicon sequencing step, we perform emulsion PCR
(emPCR) and emulsion-breaking according to the manufacturer’s protocol (Roche, Basel,
Switzerland). After the emulsion-breaking step, we enriched and counted the beads carrying
the single-stranded DNA templates, and deposited them into a PicoTiterPlate to obtain the
sequence reads.
A schematic workflow of the allele assignment process as a follow on from Figure 8 is shown
in Figure 11.
After the sequencing run, image processing, signal correction, and base calling are performed
by the GS Run Processor Ver. 3.0 (Roche) with full processing for shotgun or paired-end filter
analysis. Quality-filter sequence reads that are passed by the assembler software (single sff
file) are binned according to the MID labels into each separate sequence sff file using the sff
file software (Roche). These files are further quality trimmed to remove poor sequence at the
end of the reads with quality values (QVs) of less than 20. After separation of the trimmed and
MID-labeled sequence reads in each of forward and reverse side read sequences, we inde‐
pendently detect the Mafa-class I and Mafa-class II allele candidates from both sides of the
forward and reverse reads by using the BLAT program to match the trimmed and MID labeled
sequence reads at 99% and 100% identity while setting the minimum overlap length at 200 and
the alignment identity score parameter at 10 against all the known Mafa-class I and Mafa-class
II allele sequences released in the IMGT/MHC-NHP database [58]. After the extraction of
common allele candidates from both sequencing sides, we finally assign the “real alleles” by
confirming nucleotide sequences of the allele candidates using the GS Reference Mapper Ver.
Figure 10. Ratio of read sequence numbers obtained by amplicon sequencing of multiplex PCR products.
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3.0. To discover novel Mafa-class I sequences, we perform the de novo assembly set to detect
>85% matches using the trimmed and MID-binned sequences after converting the outputs to
ace files for the Sequencher Ver. 5.01 DNA sequence assembly software (Gene Code Co., Ann
Arbor, MI). We then use the defined consensus sequence obtained from the de novo assembly
as a reference sequence to identify and map the correct allele sequences. Using this process,
we genotyped a set of 400 unrelated animals by the Sanger sequencing method and high
resolution pyrosequencing and identified 190 different alleles, 28 at Mafa-A, 54 at Mafa-B, 12
at Mafa-I, 11 at Mafa-E, 7 at Mafa-F, 34 at Mafa-DRB, 13 at Mafa-DQA1, 13 at Mafa-DQB1, 9
at Mafa-DPA1, and 9 at Mafa-DPB1 alleles [35, 59].
On the basis of our large-scale project to genotype the MHC of 5000 Filipino cynomolgus
macaques by NGS, we so far have detected 15 different types of Mafa haplotypes (HT1~HT15)
in 45 homozygous animals. These Mafa homozygous animals provided the basis to efficiently
estimate other Mafa haplotypes. For example, we estimated a variety of Mafa-A, Mafa-B/I,
Mafa-E, and Mafa-class II (Mafa-DRB, Mafa-DQA1, Mafa-DQB1, Mafa-DPA1, and Mafa-
DPB1) haplotypes by comparing the homozygous animals with heterozygous animals that
Figure 11. A schematic workflow of the allele assignment process using the SeaBass software.
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carry the identical Mafa-class I and Mafa-class II alleles in the homozygous animals. In
addition, we estimated the Mafa haplotypes and haplotype frequencies by the PHASE 2.1.1
program [60] using the allele data obtained by amplicon sequencing. From these procedures,
we estimated a total of 84 Mafa-class I and 18 Mafa-class II haplotypes. Of the 15 different Mafa
HT haplotypes, the haplotype frequencies of HT1, HT2, HT4, and HT8 were the highest. Of
them, HT1 and HT8 have entirely different Mafa alleles, whereas HT2 and HT4 are thought
to be recombinants of HT1 and HT8 (Figure 12).
Figure 12. Gene composition of representative Mafa MHC haplotypes HT1 and HT8 and their recombinants HT2 and
HT4.
Namely, the Mafa-A allele in HT2 is identical to that in HT8, whereas HT2 also has alleles at
other loci that are identical with those in HT1. Similarly, HT4 has alleles in Mafa-class I loci
that are identical with those in HT8, and alleles in the Mafa-class II loci that are identical with
those in HT1. Therefore, Mafa homozygous animals with known haplotypes such as H1 and
H2 are important for biomedical research, such as the transplantation outcomes of induced
pluripotent stem (iPS) cells (Figure 13) because such studies are undertaken on animals with
a defined genetic background and relatively well-characterized MHC haplotypes that might
regulate the adaptive immune system in different ways and efficiencies.
5.2.2. MHC genotyping using DNA samples of wild animals
At this time in the development of MHC genotyping by NGS, it is difficult to apply the RNA-
sequencing mapping method to accurately genotype the MHC of wild animals using known
allele sequences as references. This is because the present allele information is relatively poor
for most of them (Table 5). Therefore, MHC genotyping of wild animals or poorly studied
species by NGS is based on de novo assembly of DNA sequences. In this case, the definition of
“real alleles” and “artifact alleles” is important because NGS errors such as monostretch
sequences are frequently observed in the assembled consensus sequences. Some of the allele
assignment approaches based on de novo assembly that have been published include the allele
validation threshold (AVT) method [61], clustering method [62–64], and the relative sequenc‐
ing depth modeling methods [65]. These methods suppose that the contigs that have a sequence
depth greater than the threshold level are the “real alleles,” and they are determined by
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statistical calculation of the threshold using the sequence depth values of all contigs obtained
in de novo assembly. Therefore, the detection of exact or “real” alleles depends largely on the
setting of the threshold level and the quality of the sequence reads [65]. To enable the correct
setting of the threshold level, it is important to use primers that can amplify all alleles of the
target locus or loci without allelic imbalance. Furthermore, additional considerations such as
repeating independent NGS experiments at least three times and detecting identical allele
sequences in at least two animals are necessary to distinguish between real and artifactual
alleles.
6. Conclusion
Genotyping the polymorphisms of MHC genes using targeted NGS technologies has been
developed for humans and some nonhuman species to replace the use of other more cumber‐
some and less accurate procedures. We found that targeted NGS of DNA or RNA samples is
feasible, productive, and generates high-quality MHC allele information from a large number
of samples not easily achievable by other genotyping methods. We used second-generation
sequencing protocols to target the DNA region and RNA subsets of interest in our NGS studies.
It is likely that the longer sequence reads produced by third-generation platforms such as the
Figure 13. Application of Mafa homozygous and heterozygous animals for nonclinical trials of induced pluripotent
stem (iPS) cells.
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Pacific Biosciences single-molecule real-time sequencing or the Oxford nanopore sequencing
platform will enable and improve the task of MHC sequence phasing and haplotyping,
although this has yet to be demonstrated and proved to be advantageous and more economical.
Continued allele data collection for different species, improvements to the reagents, protocols,
and data analysis tools also are likely to simplify procedures and lower the costs of generating
sequencing data in future. Most species have numerous highly polymorphic MHC loci; hence,
the many benefits of using NGS technologies are likely, in the near future, to replace many of
the traditional genotyping methods for the investigation of human and animal MHC genes
and their role in evolutionary biology, ecology, population genetics, disease, and transplan‐
tation.
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